Organizing Committee Members - NEUROLOGY 2023
Deborah Zelinsky
Director
Mind-Eye Institute
USA
Deborah Zelinsky(Biography)
Deborah Zelinsky, O.D. is an optometrist noted worldwide for her discovery of the use of eyeglasses to alter sound location, and her subsequent development of the Z-BellSM Test. This patented test allows Dr. Zelinsky and her team to prescribe lenses that synchronize the integration between auditory and visual sensory inputs. Currently, she serves as founder of The Mind-Eye Institute in Northbrook, on the board of directors for the Society for Brain Mapping and as treasurer for California Brainwaves organization. The goal in each organization is the same – to “Leave 20/20 in the 20th CenturyTM†by enhancing eye testing to include more assessments of moving targets and overall awareness of surroundings. The measurement of 20/20 eyesight does not consider the periphery or sensory integration, both of which are critical in patients. More information can be found at mindeye.com.
Deborah Zelinsky(Research Area)
Deborah Zelinsky, O.D. is an optometrist noted worldwide for her discovery of the use of eyeglasses to alter sound location, and her subsequent development of the Z-BellSM Test. This patented test allows Dr. Zelinsky and her team to prescribe lenses that synchronize the integration between auditory and visual sensory inputs. Currently, she serves as founder of The Mind-Eye Institute in Northbrook, on the board of directors for the Society for Brain Mapping and as treasurer for California Brainwaves organization. The goal in each organization is the same – to “Leave 20/20 in the 20th CenturyTM†by enhancing eye testing to include more assessments of moving targets and overall awareness of surroundings. The measurement of 20/20 eyesight does not consider the periphery or sensory integration, both of which are critical in patients. More information can be found at mindeye.com.
Gerald C. Hsu
Doctor
EclaireMD Foundation
USA
Gerald C. Hsu(Biography)
The author received an honorable PhD in mathematics and majored in engineering at MIT. He attended different universities over 17 years and studied seven academic disciplines. He has spent 20,000 hours in T2D research. First, he studied six metabolic diseases and food nutrition during 2010 to 2013, then conducted his own diabetes research during 2014 to 2018. His approach is “quantitative medicine†based on mathematics, physics, optical and electronics physics, engineering modeling, signal processing, computer science, big data analytics, statistics, machine learning, and artificial intelligence. His main focus is on preventive medicine using prediction tools. He believes that the better the prediction, the more control you have.
Gerald C. Hsu(Research Area)
The author received an honorable PhD in mathematics and majored in engineering at MIT. He attended different universities over 17 years and studied seven academic disciplines. He has spent 20,000 hours in T2D research. First, he studied six metabolic diseases and food nutrition during 2010 to 2013, then conducted his own diabetes research during 2014 to 2018. His approach is “quantitative medicine†based on mathematics, physics, optical and electronics physics, engineering modeling, signal processing, computer science, big data analytics, statistics, machine learning, and artificial intelligence. His main focus is on preventive medicine using prediction tools. He believes that the better the prediction, the more control you have.
Nikolas Tezapsidis
Founder
Neurotez, Inc
USA
Nikolas Tezapsidis(Biography)
Dr. Tezapsidis is the founder of Neurotez, Inc. and has been the President, Chief Executive Officer and Chairman of the Board of Directors since the company was incorporated in 2005. Nikolaos raised funds through non-dilutive capital sources while building the company, recruiting top talent, maintaining top notch research and development programs and establishing a strong patent portfolio. A few years ago he negotiated a milestone-linked $100 million deal exclusive for China and a partnership with Memtrax for a new memory screening test for Alzheimer’s patients. Currently Neurotez is raising funds for clinical trials testing leptin to treat Alzheimer’s. Recipient of two awards from the Alzheimer’s Association, USA and fellowships from the Wellcome Trust and the Science and Engineering Council, UK. He has several patents issued and pending both in the US and in foreign markets and is the author of more than fifty publications. Dr. Tezapsidis received a Bachelor of Science in Chemistry from the Aristotle University, Greece and completed his Master of Science and Doctor of Philosophy in Biochemistry at the University of Sussex, UK. Nik has been interviewed by The National Herald (http://www.thenationalherald.com/?s=tezapsidis), BioCenturyTV, 1800LiveRadioInterview, and Ellines (https://www.ellines.com/en/category/famous-greeks/ ).
Nikolas Tezapsidis(Research Area)
Dr. Tezapsidis is the founder of Neurotez, Inc. and has been the President, Chief Executive Officer and Chairman of the Board of Directors since the company was incorporated in 2005. Nikolaos raised funds through non-dilutive capital sources while building the company, recruiting top talent, maintaining top notch research and development programs and establishing a strong patent portfolio. A few years ago he negotiated a milestone-linked $100 million deal exclusive for China and a partnership with Memtrax for a new memory screening test for Alzheimer’s patients. Currently Neurotez is raising funds for clinical trials testing leptin to treat Alzheimer’s. Recipient of two awards from the Alzheimer’s Association, USA and fellowships from the Wellcome Trust and the Science and Engineering Council, UK. He has several patents issued and pending both in the US and in foreign markets and is the author of more than fifty publications. Dr. Tezapsidis received a Bachelor of Science in Chemistry from the Aristotle University, Greece and completed his Master of Science and Doctor of Philosophy in Biochemistry at the University of Sussex, UK. Nik has been interviewed by The National Herald (http://www.thenationalherald.com/?s=tezapsidis), BioCenturyTV, 1800LiveRadioInterview, and Ellines (https://www.ellines.com/en/category/famous-greeks/ ).
Brandon Lucke Wold
Professor
University of Florida
USA
Brandon Lucke Wold(Biography)
Brandon Lucke-Wold was born and raised in Colorado Springs, CO. He graduated magna cum laude with a BS in Neuroscience and distinction in honors from Baylor University. He completed his MD/PhD, Master’s in Clinical and Translational Research, and the Global Health Track at West Virginia University School of Medicine. His research focus was on traumatic brain injury, neurosurgical simulation, and stroke. At West Virginia University, he also served as a health coach for the Diabetes Prevention and Management program in Morgantown and Charleston, WV, which significantly improved health outcomes for participants. In addition to his research and public health projects, he is a co-founder of the biotechnology company Wright-Wold Scientific, the pharmaceutical company CTE cure, and was a science advocate on Capitol Hill through the Washington Fellow’s program.
Brandon Lucke Wold(Research Area)
Brandon Lucke-Wold was born and raised in Colorado Springs, CO. He graduated magna cum laude with a BS in Neuroscience and distinction in honors from Baylor University. He completed his MD/PhD, Master’s in Clinical and Translational Research, and the Global Health Track at West Virginia University School of Medicine. His research focus was on traumatic brain injury, neurosurgical simulation, and stroke. At West Virginia University, he also served as a health coach for the Diabetes Prevention and Management program in Morgantown and Charleston, WV, which significantly improved health outcomes for participants. In addition to his research and public health projects, he is a co-founder of the biotechnology company Wright-Wold Scientific, the pharmaceutical company CTE cure, and was a science advocate on Capitol Hill through the Washington Fellow’s program.
Hossein Ansari
Professor
Vc-health Sciences-schools
Canada
Hossein Ansari(Biography)
Hossein Ansari, MD, is a board-certified neurologist and certified headache specialist who specializes in diagnosing and treating headaches and facial pain. He is highly experienced in caring for people with migraines, "cluster" headaches and trigeminal neuralgia. Dr. Ansari's clinical expertise also includes developing guidelines for managing headaches in the emergency room, trigeminal neuropathy, Botox administration and nerve blocks and sphenopalatine ganglion (SPG) block procedures for head/face pain, and neurological problems resulting from systemic disease. Prior to joining UC San Diego Health, Dr. Ansari established a multidisciplinary headache center at The Neuroscience Center at Neurology & Neuroscience Associates Inc. in Akron, Ohio, and served as the headache center's director. He was also an assistant professor at Northeast Ohio Medical University and an attending neurologist at Summa Health System. Dr. Ansari has authored articles and book chapters on headache diagnosis and management. He lectures frequently on this topic and has presented at both national and international conferences. He completed his fellowship on headache and facial pain at the Mayo Clinic in Rochester, Minnesota, and his neurology residency at West Virginia University, Morgantown. Dr. Ansari earned his medical degree from Urmia University of Medical Sciences in Iran. He is board certified in neurology and holds subspecialty certification in headache medicine from the United Council for Neurologic Subspecialties. Dr. Ansari is a fellow of both the American Academy of Neurology (FAAN) and the American Headache Society (FAHS). He is an active member of numerous professional societies, including the International Headache Society, where he serves on the advisory council.
Hossein Ansari(Research Area)
Hossein Ansari, MD, is a board-certified neurologist and certified headache specialist who specializes in diagnosing and treating headaches and facial pain. He is highly experienced in caring for people with migraines, "cluster" headaches and trigeminal neuralgia. Dr. Ansari's clinical expertise also includes developing guidelines for managing headaches in the emergency room, trigeminal neuropathy, Botox administration and nerve blocks and sphenopalatine ganglion (SPG) block procedures for head/face pain, and neurological problems resulting from systemic disease. Prior to joining UC San Diego Health, Dr. Ansari established a multidisciplinary headache center at The Neuroscience Center at Neurology & Neuroscience Associates Inc. in Akron, Ohio, and served as the headache center's director. He was also an assistant professor at Northeast Ohio Medical University and an attending neurologist at Summa Health System. Dr. Ansari has authored articles and book chapters on headache diagnosis and management. He lectures frequently on this topic and has presented at both national and international conferences. He completed his fellowship on headache and facial pain at the Mayo Clinic in Rochester, Minnesota, and his neurology residency at West Virginia University, Morgantown. Dr. Ansari earned his medical degree from Urmia University of Medical Sciences in Iran. He is board certified in neurology and holds subspecialty certification in headache medicine from the United Council for Neurologic Subspecialties. Dr. Ansari is a fellow of both the American Academy of Neurology (FAAN) and the American Headache Society (FAHS). He is an active member of numerous professional societies, including the International Headache Society, where he serves on the advisory council.
Ken Ware
Founder
NeuroPhysics Therapy Institute
Australia
Ken Ware(Biography)
Ken Ware was founder of Neurotricional Sciences Pty Ltd and NeuroPhysics Therapy and Research and he had been in private practice for almost 30 years, while doing independent and collaborative research. He also presented unique research at 10 major International Science Conferences including neuroscience, Physics, Psychology and Life Sciences, which covers a very broad scientific audience. He is Former Mr. Universe 1994, National powerlifting and Bodybuilding champion and record holder. He had published relative publications in ‘Frontiers in Clinical Physiology’ - ‘World Journal of Neuroscience’ – ‘World Journal of Cardiovascular diseases’. He is recipient of Her Majesty, Queen Elizabeth’s’ ‘Australian Sports Medal’ - in 2000, in recognition for personal contributions to the development of the Australian Sporting Culture.
Ken Ware(Research Area)
Ken Ware was founder of Neurotricional Sciences Pty Ltd and NeuroPhysics Therapy and Research and he had been in private practice for almost 30 years, while doing independent and collaborative research. He also presented unique research at 10 major International Science Conferences including neuroscience, Physics, Psychology and Life Sciences, which covers a very broad scientific audience. He is Former Mr. Universe 1994, National powerlifting and Bodybuilding champion and record holder. He had published relative publications in ‘Frontiers in Clinical Physiology’ - ‘World Journal of Neuroscience’ – ‘World Journal of Cardiovascular diseases’. He is recipient of Her Majesty, Queen Elizabeth’s’ ‘Australian Sports Medal’ - in 2000, in recognition for personal contributions to the development of the Australian Sporting Culture.
Roberto Di Maio
Professor
University of Pittsburgh
United States
Roberto Di Maio(Biography)
Dr. Di Maio studied Biomedicine at the University of Palermo (Italy) and graduated in 1991. In 1993, he joined the Mario Negri Sud Research Institute, (Italy) where he obtained his master’s degree in Pharmacology in 1996. He then joined the research group of Prof. Vittorio La Grutta at the Institute of Human Physiology, University of Palermo (Italy) where he received his PhD degree in Neurosciences in 2005. After three years of postdoctoral fellowship supervised by Dr. Greenamyre at the Pittsburgh Institute for Neurodegenerative Diseases (University of Pittsburgh, Pittsburgh – USA), He has been appointed as Assistant Professor at the same Institution. He has published more than 40 research articles in SCI(E) journals.
Roberto Di Maio(Research Area)
..
Roy G Beran
consultant neurologist
School of Medicine at Griffith University
Australia
Roy G Beran(Biography)
Roy G. Beran is trained as a consultant neurologist and accredited sleep physician, in addition to working within legal medicine, military medicine and aviation medicine. His qualifications include: MBBS, MD, FRACP, FRACGP, Grad. Dip. Tertiary Ed., Grad. Dip. Further Ed., FAFPHM, FACLM, FRCP, FAAN, FACBS, B Leg. S, MHL and FFFLM (Hon). He is registered with the Australian Health Practitioner Regulation Agency (AHPRA) as a specialist in Neurology, Public Health and Sleep Medicine and was a Designated Medical Examiner for the Civil Aviation Safety Authority, a medical assessor for Dispute Resolution for the State Insurance Regulatory Authority and an assessor for the Workers Compensation Commission of New South Wales (NSW). He is a Conjoint Professor of Medicine at the University of NSW; Professor in the School of Medicine at Griffith University, Queensland; and Professor, Chair, Medical Law, Sechenov Moscow 1st State University, Moscow, Russia. He was the inaugural Visiting Professor at the International Research Institute of Health Law Sciences at the Southern Medical University, Guangzhou, Guangdong Province, China. He was also a visiting professor to the Macau University and is co-editor of the textbook, ‘Legal Liability in Asia and Australasia’, with Prof Raposo from that university. He is: a founding Fellow of the Australasian College of Legal Medicine; a Past President of the College, having stepped down in 2011, while remaining on Council, and was awarded the second ever Honorary Life Fellowship of the College. In 2019, he was appointed as ‘Co-Head of Faculty’ to convene and co-ordinate the College’s training courses throughout Australia. He is the Australian Governor and was the Secretary General and remains a Vice President of the World Association for Medical Law (WAML), having served on the Organising Committee of numerous World Congresses on Medical Law, presided over the World Congress, in Sydney, in 2004, and successfully bid to host the World Congress, to be held on the Gold Coast, Queensland, in 2022. He was the first Honorary Fellow of the Faculty of Forensic & Legal Medicine of the Royal College of Physicians (London). In Neurology, he is: a Fellow of the Royal Australasian College of Physicians; a Fellow of the Royal College of Physicians, Edinburgh; Corresponding Fellow of the American Academy of Neurologists; and a Member of the Australian and New Zealand Association of Neurologists. He is a Member of the Australasian Sleep Association, serving on various committees thereof. He pioneered the conduct of clinical trials and undertaking research within private practice, having been principal author in publications which included leading academic/tertiary referral institutions. He has published more than 360 papers, book chapters and letters to the editor, presented in excess of 400 papers at national and international meetings and written or edited 17 books, including ‘Legal and Forensic Medicine’, and is on numerous editorial boards, including being the editor in chief of the international journal, Medicine and Law, for the WAML.
Roy G Beran(Research Area)
His research interests include: Concussion; Epilepsy; Legal Medicine; Stroke; Sleep; Neuroepidemiology; and Medical Education. He was an officer in the Royal Australian Navy Reserve (holding the rank of Commander) and was awarded membership of the general division of the Order of Australia, in 2015.